Cardio Cases · valvular-heart-disease
Flash pulmonary oedema after inferior MI — case discussion
Practice case: a 71-year-old with flash pulmonary oedema two days after an inferior MI, covering recognition of a mechanical complication, papillary muscle rupture, stabilisation and the choice between surgery and transcatheter repair, using the 2025 ESC/EACTS, 2023 ESC ACS and 2020 ACC/AHA guidelines.
On this page
Study tools
Target exams
- EECC
- ABIM Cardiovascular Disease Certification
- consultant-call scenario
Prompt
A 71-year-old woman is two days post inferior ST-elevation MI treated with primary PCI to a right coronary artery occlusion. She calls the nurse for breathlessness at 3 am and is found saturating 84% on room air, respiratory rate 34, BP 96/58, HR 104 sinus, bibasal crackles. A new soft, short systolic murmur is heard at the apex. She has no previous cardiac history.
Objectives
- Recognise a post-infarction mechanical complication from its clinical clues.[3]
- Confirm acute severe MR and its mechanism with immediate echocardiography.[3][2]
- Stabilise the circulation as a bridge, not a destination.[1][2]
- Choose definitive treatment for papillary muscle rupture, and know where transcatheter repair fits.[1][3]
Candidate brief
You are the cardiology consultant on call. You have twenty minutes to present assessment, stabilisation, definitive plan and disposition.
Expected actions
- Recognise the pattern. Sudden hypotension, a new murmur suggesting acute MR or a septal defect, and pulmonary congestion should raise suspicion of a mechanical complication.[3] Acute MR is often missed or delayed because it presents differently from chronic MR.[4] Its murmur may be short and unimpressive.[2]
- Image immediately. ESC 2023 ACS says immediate echocardiographic assessment is indicated when a mechanical complication is suspected.[3] TTE comes first. After infarction with sudden haemodynamic instability, a hyperdynamic LV on TTE and no other cause for the deterioration, TOE can be especially helpful in detecting papillary muscle or chordal rupture.[2]
- Stabilise. The ESC/EACTS 2025 text notes that inotropes and diuretics are usually indicated to reduce filling pressure and control congestion in acute primary MR.[1] ESC/EACTS 2025 says nitroprusside has been used as a bridge in patients without signs of hypotension, and ACC/AHA 2020 notes vasodilator use is often limited by systemic hypotension, so a vasodilator is an option only if she has no signs of hypotension; doses per local formulary and specialist guidance.[1][2] ESC 2023 ACS states that patients with ACS-related mechanical complications should be considered for IABP while awaiting surgery.[3] A percutaneous circulatory assist device may stabilise her before the procedure.[2]
- Treat the valve urgently. Untreated acute valvular decompensation progresses to cardiogenic shock.[6] The ESC/EACTS 2025 text says urgent surgery or transcatheter treatment is indicated for acute severe primary MR; papillary muscle rupture generally needs surgical valve replacement.[1] ESC 2023 ACS states that surgery is currently regarded as the treatment of choice for ACS mechanical complications.[3]
- Know the transcatheter role. Percutaneous strategies are occasionally used in selected patients with a prohibitive risk profile or contraindications to surgery.[3] For acute primary MR in general, such as a flail leaflet, one review describes edge-to-edge repair as an alternative in an emergency at high surgical risk.[4] ESC/EACTS 2025 cites increasing evidence for M-TEER in acute ventricular secondary MR, particularly after infarction, a different mechanism from rupture.[1]
- Disposition. ESC 2023 ACS calls a multidisciplinary approach of paramount importance at all stages, from initial stabilisation to the treatment strategy.[3] For severe acute MR after infarction, medical management alone carries the worst prognosis.[5]
Marking
Pass:
- names a mechanical complication, including papillary muscle rupture or septal rupture, and orders immediate echocardiography.[3][1]
- recognises that the murmur of acute severe MR may be short and unimpressive.[2]
- stabilises with diuretics and inotropes, uses vasodilators only without signs of hypotension (recognising that hypotension often limits them), and considers IABP or circulatory support as a bridge.[1][2][3]
- if echocardiography shows papillary muscle rupture, refers for urgent surgery, usually surgical valve replacement.[1]
- recognises that percutaneous strategies are occasionally used in selected patients with a prohibitive risk profile or contraindications to surgery (ESC 2023 ACS).[3][4]
Fail:
- delays echocardiography for other imaging, such as CT pulmonary angiography, despite a new murmur after infarction.[3]
- relies on medical therapy alone and defers the surgical decision.[5][3]
- starts nitroprusside despite signs of hypotension.[1][2]
- manages her as chronic MR with outpatient GDMT titration.[1]
References6ShowHide
- [1]Praz F, Borger MA, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2025.PMID 40878295
- [2]Otto CM, Nishimura RA, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021.PMID 33332150
- [3]Byrne RA et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J, 2023.PMID 37622654
- [4]Watanabe N et al. Acute mitral regurgitation. Heart, 2019.PMID 30824479
- [5]Estévez-Loureiro R et al. Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5. J Am Coll Cardiol, 2024.PMID 38692830
- [6]Lüsebrink E et al. Management of acute decompensated valvular heart disease. Eur J Heart Fail, 2025.PMID 39663714